Psychedelic therapy unites two basic, and often opposing, views as to the best approach to mental health treatment, Robin Carhart-Harris, PhD, explained at the 2020 virtual Psych Congress Elevate conference.
A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.
SAN FRANCISCO—Alcohol use and cravings decreased in participants with higher scores on the Mystical Experience Questionnaire in a controlled study assessing psilocybin-assisted psychotherapy for alcohol dependence, according to preliminary results presented at the American Psychiatric Association’s annual meeting.
A single dose of the psychedelic drug methylendioxymethamphetamine (MDMA) reopens the critical period for learning the reward value of social behaviors, according to a study published online in Nature.